Inhibition of H1N1 influenza A virus growth and induction of inflammatory mediators by the isoquinoline alkaloid berberine and extracts of goldenseal (Hydrastis canadensis)

International Immunopharmacology

Volumn 11, Issue 11, 2011, Pages 1706-1714

  Cecil, Chad E ^a   Davis, Jeanine M ^a   Cech, Nadja B ^b   Laster, Scott M ^a  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

^b UNIVERSITY OF NORTH CAROLINA AT GREENSBORO   (United States)

Author keywords

Anti viral; Berberine; Cytokines; Goldenseal; H1N1 influenza A; Lipid mediators

Indexed keywords

ANTIVIRUS AGENT; BERBERINE; HYDRASTIS CANADENSIS EXTRACT; PLANT EXTRACT; PROSTAGLANDIN E2; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CELL MIGRATION; CONCENTRATION RESPONSE; CYTOKINE PRODUCTION; DRUG MECHANISM; HUMAN; HUMAN CELL; HYDRASTIS; INFLUENZA A (H1N1); INFLUENZA VIRUS A H1N1; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROCESSING; VIROGENESIS; VIRUS INHIBITION; VIRUS REPLICATION;

ANIMALS; ANTIVIRAL AGENTS; BERBERINE; CELL CULTURE TECHNIQUES; CELL LINE; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; HYDRASTIS; IMMUNOBLOTTING; IMMUNOLOGIC FACTORS; INFLUENZA A VIRUS, H1N1 SUBTYPE; MACROPHAGES; MICE; MICE, INBRED C57BL; MICROSCOPY, FLUORESCENCE; PLANT EXTRACTS; VIRAL PROTEINS;

EID: 80054974876     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2011.06.002     Document Type: Article

References (74)

1. B.N. Fields, D.M. Knipe, and P.M. Howley Fields' virology 5th ed 2007 Wolters Kluwer Health/Lippincott Williams & Wilkins Philadelphia 1 online resource (3091 p.)
2. N.M. Bouvier, and P. Palese The biology of influenza viruses Vaccine 26 Suppl 4 2008 D49 D53
3. F.R. Stermitz, P. Lorenz, J.N. Tawara, L.A. Zenewicz, and K. Lewis Synergy in a medicinal plant: antimicrobial action of berberine potentiated by 5′-methoxyhydnocarpin, a multidrug pump inhibitor Proc Natl Acad Sci USA 97 2000 1433 1437 (Pubitemid 30118458)
4. T. Kuiken, and J.K. Taubenberger Pathology of human influenza revisited Vaccine 26 Suppl 4 2008 D59 D66
5. C.A. Conn, J.L. McClellan, H.F. Maassab, C.W. Smitka, J.A. Majde, and M.J. Kluger Cytokines and the acute phase response to influenza virus in mice Am J Physiol 268 1995 R78 R84
6. R.S. Fritz, F.G. Hayden, D.P. Calfee, L.M. Cass, A.W. Peng, and W.G. Alvord Nasal cytokine and chemokine responses in experimental influenza A virus infection: results of a placebo-controlled trial of intravenous zanamivir treatment J Infect Dis 180 1999 586 593 (Pubitemid 29411341)
7. D. Gentile, W. Doyle, T. Whiteside, P. Fireman, F.G. Hayden, and D. Skoner Increased interleukin-6 levels in nasal lavage samples following experimental influenza A virus infection Clin Diagn Lab Immunol 5 1998 604 608 (Pubitemid 29030752)
8. F.G. Hayden, R. Fritz, M.C. Lobo, W. Alvord, W. Strober, and S.E. Straus Local and systemic cytokine responses during experimental human influenza A virus infection. Relation to symptom formation and host defense J Clin Invest 101 1998 643 649 (Pubitemid 28084248)
9. R.L. Peper, and H. Van Campen Tumor necrosis factor as a mediator of inflammation in influenza A viral pneumonia Microb Pathog 19 1995 175 183
10. D.P. Skoner, D.A. Gentile, A. Patel, and W.J. Doyle Evidence for cytokine mediation of disease expression in adults experimentally infected with influenza A virus J Infect Dis 180 1999 10 14 (Pubitemid 29293911)
11. F. Vacheron, A. Rudent, S. Perin, C. Labarre, A.M. Quero, and M. Guenounou Production of interleukin 1 and tumour necrosis factor activities in bronchoalveolar washings following infection of mice by influenza virus J Gen Virol 71 Pt 2 1990 477 479 (Pubitemid 20059150)
12. I. Julkunen, T. Sareneva, J. Pirhonen, T. Ronni, K. Melen, and S. Matikainen Molecular pathogenesis of influenza A virus infection and virus-induced regulation of cytokine gene expression Cytokine Growth Factor Rev 12 2001 171 180 (Pubitemid 32588143)
13. F. Hayden Developing new antiviral agents for influenza treatment: what does the future hold? Clin Infect Dis 48 Suppl 1 2009 S3 S13
14. M. Grieve A modern herbal 1971 Dover Publications, Inc New York
15. M. Imanshahidi, and H. Hosseinzadeh Pharmacological and therapeutic effects of Berberis vulgaris and its active constituent, berberine Phytother Res 22 2008 999 1012
16. M.S. Choi, J.H. Oh, S.M. Kim, H.Y. Jung, H.S. Yoo, and Y.M. Lee Berberine inhibits p53-dependent cell growth through induction of apoptosis of prostate cancer cells Int J Oncol 34 2009 1221 1230
17. Y.T. Ho, J.S. Yang, C.C. Lu, J.H. Chiang, T.C. Li, and J.J. Lin Berberine inhibits human tongue squamous carcinoma cancer tumor growth in a murine xenograft model Phytomedicine 16 2009 887 890
18. J.B. Kim, K.M. Lee, E. Ko, W. Han, J.E. Lee, and I. Shin Berberine inhibits growth of the breast cancer cell lines MCF-7 and MDA-MB-231 Planta Med 74 2008 39 42 (Pubitemid 351251381)
19. J.B. Patil, J. Kim, and G.K. Jayaprakasha Berberine induces apoptosis in breast cancer cells (MCF-7) through mitochondrial-dependent pathway Eur J Pharmacol 645 2010 70 78
20. L. Pinto-Garcia, T. Efferth, A. Torres, J.D. Hoheisel, and M. Youns Berberine inhibits cell growth and mediates caspase-independent cell death in human pancreatic cancer cells Planta Med 76 2010 1155 1161
21. S. Samosorn, B. Tanwirat, N. Muhamad, G. Casadei, D. Tomkiewicz, and K. Lewis Antibacterial activity of berberine-NorA pump inhibitor hybrids with a methylene ether linking group Bioorg Med Chem 17 2009 3866 3872
22. A.H. Amin, T.V. Subbaiah, and K.M. Abbasi Berberine sulfate: antimicrobial activity, bioassay, and mode of action Can J Microbiol 15 1969 1067 1076
23. Z. Kowalewski, W. Kedzia, and I. Mirska The effect of berberine sulfate on staphylococci Arch Immunol Ther Exp (Warsz) 20 1972 353 360
24. S. Pepeljnjak, and J. Petricic The antimicrobic effect of berberine and tinctura berberidis Pharmazie 47 1992 307 308
25. T. Schmeller, B. Latz-Bruning, and M. Wink Biochemical activities of berberine, palmatine and sanguinarine mediating chemical defence against microorganisms and herbivores Phytochemistry 44 1997 257 266 (Pubitemid 27087925)
26. K.A. Ettefagh, J.T. Burns, H.A. Junio, G.W. Kaatz, and N.B. Cech Goldenseal (Hydrastis canadensis L.) extracts synergistically enhance the antibacterial activity of berberine via efflux pump inhibition Planta Med 77 8 2011 835 840
27. L.W. Chin, Y.W. Cheng, S.S. Lin, Y.Y. Lai, L.Y. Lin, and M.Y. Chou Anti-herpes simplex virus effects of berberine from Coptidis rhizoma, a major component of a Chinese herbal medicine, Ching-Wei-San Arch Virol 155 2010 1933 1941
28. K.B. Harikumar, G. Kuttan, and R. Kuttan Inhibition of progression of erythroleukemia induced by Friend virus in BALB/c mice by natural products-berberine, curcumin and picroliv J Exp Ther Oncol 7 2008 275 284
29. K. Hayashi, K. Minoda, Y. Nagaoka, T. Hayashi, and S. Uesato Antiviral activity of berberine and related compounds against human cytomegalovirus Bioorg Med Chem Lett 17 2007 1562 1564
30. D.U. Lee, Y.J. Kang, M.K. Park, Y.S. Lee, H.G. Seo, and T.S. Kim Effects of 13-alkyl-substituted berberine alkaloids on the expression of COX-II, TNF-alpha, iNOS, and IL-12 production in LPS-stimulated macrophages Life Sci 73 2003 1401 1412 (Pubitemid 36798127)
31. F. Li, H.D. Wang, D.X. Lu, Y.P. Wang, R.B. Qi, and Y.M. Fu Neutral sulfate berberine modulates cytokine secretion and increases survival in endotoxemic mice Acta Pharmacol Sin 27 2006 1199 1205 (Pubitemid 44411001)
32. A. Lesnau, J. Hils, G. Pohl, G. Beyer, M. Janka, and L.T. Hoa Antiviral activity of berberine salts Pharmazie 45 1990 638 639
33. Y. Sidorenko, and U. Reichl Structured model of influenza virus replication in MDCK cells Biotechnol Bioeng 88 2004 1 14 (Pubitemid 39388688)
34. D. Vester, A. Lagoda, D. Hoffmann, C. Seitz, S. Heldt, and K. Bettenbrock Real-time RT-qPCR assay for the analysis of human influenza A virus transcription and replication dynamics J Virol Methods 168 2010 63 71
35. F.G. Hayden, K.M. Cote, and R.G. Douglas Jr. Plaque inhibition assay for drug susceptibility testing of influenza viruses Antimicrob Agents Chemother 17 1980 865 870 (Pubitemid 10112539)
36. M.R. Dumitrescu, M. Grobnicu, and E. Zilisteanu Use of MDCK cell line for isolation of influenza virus strains Arch Roum Pathol Exp Microbiol 39 1980 245 248 (Pubitemid 11144303)
37. J. Reina, V. Fernandez-Baca, I. Blanco, and M. Munar Comparison of Madin-Darby canine kidney cells (MDCK) with a green monkey continuous cell line (Vero) and human lung embryonated cells (MRC-5) in the isolation of influenza A virus from nasopharyngeal aspirates by shell vial culture J Clin Microbiol 35 1997 1900 1901 (Pubitemid 27255687)
38. S.K. Schepetiuk, and T. Kok The use of MDCK, MEK and LLC-MK2 cell lines with enzyme immunoassay for the isolation of influenza and parainfluenza viruses from clinical specimens J Virol Methods 42 1993 241 250
39. I.C. Huang, W. Li, J. Sui, W. Marasco, H. Choe, and M. Farzan Influenza A virus neuraminidase limits viral superinfection J Virol 82 2008 4834 4843 (Pubitemid 351657045)
40. D.P. Nayak, E.K. Hui, and S. Barman Assembly and budding of influenza virus Virus Res 106 2004 147 165 (Pubitemid 39572961)
41. C.H. Lee, J.C. Chen, C.Y. Hsiang, S.L. Wu, H.C. Wu, and T.Y. Ho Berberine suppresses inflammatory agents-induced interleukin-1beta and tumor necrosis factor-alpha productions via the inhibition of IkappaB degradation in human lung cells Pharmacol Res 56 2007 193 201
42. F.L. Chen, Z.H. Yang, Y. Liu, L.X. Li, W.C. Liang, and X.C. Wang Berberine inhibits the expression of TNFalpha, MCP-1, and IL-6 in AcLDL-stimulated macrophages through PPARgamma pathway Endocrine 33 2008 331 337
43. J.H. Gong, H. Sprenger, F. Hinder, A. Bender, A. Schmidt, and S. Horch Influenza A virus infection of macrophages. Enhanced tumor necrosis factor-alpha (TNF-alpha) gene expression and lipopolysaccharide-triggered TNF-alpha release J Immunol 147 1991 3507 3513
44. K. Kuwano, T. Kawashima, and S. Arai Antiviral effect of TNF-alpha and IFN-gamma secreted from a CD8+ influenza virus-specific CTL clone Viral Immunol 6 1993 1 11 (Pubitemid 23108502)
45. C. Lehmann, H. Sprenger, M. Nain, M. Bacher, and D. Gemsa Infection of macrophages by influenza A virus: characteristics of tumour necrosis factor-alpha (TNF alpha) gene expression Res Virol 147 1996 123 130 (Pubitemid 26108129)
46. V. Veckman, P. Osterlund, R. Fagerlund, K. Melen, S. Matikainen, and I. Julkunen TNF-alpha and IFN-alpha enhance influenza-A-virus-induced chemokine gene expression in human A549 lung epithelial cells Virology 345 2006 96 104 (Pubitemid 43107575)
47. M.A. Carey, J.A. Bradbury, J.M. Seubert, R. Langenbach, D.C. Zeldin, and D.R. Germolec Contrasting effects of cyclooxygenase-1 (COX-1) and COX-2 deficiency on the host response to influenza A viral infection J Immunol 175 2005 6878 6884 (Pubitemid 41598933)
48. K. Mizumura, S. Hashimoto, S. Maruoka, Y. Gon, N. Kitamura, and K. Matsumoto Role of mitogen-activated protein kinases in influenza virus induction of prostaglandin E2 from arachidonic acid in bronchial epithelial cells Clin Exp Allergy 33 2003 1244 1251 (Pubitemid 37108529)
49. N.B. Cech, V. Kandhi, J.M. Davis, A. Hamilton, D. Eads, and S.M. Laster Echinacea and its alkylamides: effects on the influenza A-induced secretion of cytokines, chemokines, and PGE from RAW 264.7 macrophage-like cells Int Immunopharmacol 10 2010 1268 1278
50. M. Hamzawi, R. Jennings, and C.W. Potter The amantadine-sensitivity of recombinant and parental influenza virus strains Med Microbiol Immunol 169 1981 259 268 (Pubitemid 11095439)
51. N. Wang, Y. Feng, E.P. Lau, C. Tsang, Y. Ching, and K. Man F-actin reorganization and inactivation of rho signaling pathway involved in the inhibitory effect of Coptidis rhizoma on hepatoma cell migration Integr Cancer Ther 9 2010 354 364
52. Q. Zhang, X. Xiao, K. Feng, T. Wang, W. Li, and T. Yuan Berberine moderates glucose and lipid metabolism through multipathway mechanism Evid Based Complement Alternat Med 2011 2011 1 10
53. P. Giri, and G.S. Kumar Isoquinoline alkaloids and their binding with polyadenylic acid: potential basis of therapeutic action Mini Rev Med Chem 10 2010 568 577
54. G. Cui, X. Qin, Y. Zhang, Z. Gong, B. Ge, and Y.Q. Zang Berberine differentially modulates the activities of ERK, p38 MAPK, and JNK to suppress Th17 and Th1 T cell differentiation in type 1 diabetic mice J Biol Chem 284 2009 28420 28429
55. M. Ueda, M. Yamate, A. Du, T. Daidoji, Y. Okuno, and K. Ikuta Maturation efficiency of viral glycoproteins in the ER impacts the production of influenza A virus Virus Res 136 2008 91 97
56. C. Seitz, T. Frensing, D. Hoper, G. Kochs, and U. Reichl High yields of influenza A virus in Madin-Darby canine kidney cells are promoted by an insufficient interferon-induced antiviral state J Gen Virol 91 2010 1754 1763
57. H.L. Lin, T.Y. Liu, W.Y. Lui, and C.W. Chi Up-regulation of multidrug resistance transporter expression by berberine in human and murine hepatoma cells Cancer 85 1999 1937 1942
58. H.L. Lin, T.Y. Liu, C.W. Wu, and C.W. Chi Berberine modulates expression of mdr1 gene product and the responses of digestive track cancer cells to Paclitaxel Br J Cancer 81 1999 416 422
59. J. McGill, J.W. Heusel, and K.L. Legge Innate immune control and regulation of influenza virus infections J Leukoc Biol 86 2009 803 812
60. S. Tamura, and T. Kurata Defense mechanisms against influenza virus infection in the respiratory tract mucosa Jpn J Infect Dis 57 2004 236 247 (Pubitemid 40260238)
61. S. Akira TLR signaling Curr Top Microbiol Immunol 311 2006 1 16 (Pubitemid 47413193)
62. K. Onomoto, M. Yoneyama, and T. Fujita Regulation of antiviral innate immune responses by RIG-I family of RNA helicases Curr Top Microbiol Immunol 316 2007 193 205
63. M. Yoneyama, and T. Fujita RIG-I family RNA helicases: cytoplasmic sensor for antiviral innate immunity Cytokine Growth Factor Rev 18 2007 545 551 (Pubitemid 47302820)
64. I.C. Allen, M.A. Scull, C.B. Moore, E.K. Holl, E. McElvania-TeKippe, and D.J. Taxman The NLRP3 inflammasome mediates in vivo innate immunity to influenza A virus through recognition of viral RNA Immunity 30 2009 556 565
65. H. Kumar, T. Kawai, H. Kato, S. Sato, K. Takahashi, and C. Coban Essential role of IPS-1 in innate immune responses against RNA viruses J Exp Med 203 2006 1795 1803 (Pubitemid 44036284)
66. J. Hiscott, T.L. Nguyen, M. Arguello, P. Nakhaei, and S. Paz Manipulation of the nuclear factor-kappaB pathway and the innate immune response by viruses Oncogene 25 2006 6844 6867 (Pubitemid 44657856)
67. M.J. Servant, N. Grandvaux, and J. Hiscott Multiple signaling pathways leading to the activation of interferon regulatory factor 3 Biochem Pharmacol 64 2002 985 992 (Pubitemid 35232273)
68. S. Ludwig, S. Pleschka, O. Planz, and T. Wolff Ringing the alarm bells: signalling and apoptosis in influenza virus infected cells Cell Microbiol 8 2006 375 386 (Pubitemid 43356029)
69. I. Julkunen, K. Melen, M. Nyqvist, J. Pirhonen, T. Sareneva, and S. Matikainen Inflammatory responses in influenza A virus infection Vaccine 19 Suppl 1 2000 S32 S37 (Pubitemid 32121717)
70. R.C. Yadav, G.S. Kumar, K. Bhadra, P. Giri, R. Sinha, and S. Pal Berberine, a strong polyriboadenylic acid binding plant alkaloid: spectroscopic, viscometric, and thermodynamic study Bioorg Med Chem 13 2005 165 174 (Pubitemid 39575701)
71. R. Nandi, D. Debnath, and M. Maiti Interactions of berberine with poly(A) and tRNA Biochim Biophys Acta 1049 1990 339 342 (Pubitemid 20224630)
72. Y.T. Ho, J.S. Yang, T.C. Li, J.J. Lin, J.G. Lin, and K.C. Lai Berberine suppresses in vitro migration and invasion of human SCC-4 tongue squamous cancer cells through the inhibitions of FAK, IKK, NF-kappaB, u-PA and MMP-2 and -9 Cancer Lett 279 2009 155 162
73. S. Kim, J.H. Choi, J.B. Kim, S.J. Nam, J.H. Yang, and J.H. Kim Berberine suppresses TNF-alpha-induced MMP-9 and cell invasion through inhibition of AP-1 activity in MDA-MB-231 human breast cancer cells Molecules 13 2008 2975 2985
74. B.Y. Kang, S.W. Chung, D. Cho, and T.S. Kim Involvement of p38 mitogen-activated protein kinase in the induction of interleukin-12 p40 production in mouse macrophages by berberine, a benzodioxoloquinolizine alkaloid Biochem Pharmacol 63 2002 1901 1910 (Pubitemid 34603455)